Skip to content

Clinical trials

Completed Phase 2/3 Carcinoma, Non-Small-Cell Lung trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 2/3 Status: Completed Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20053
20061
20072
20081
20091
20111
20131
20141
20153
20181
20191
20201
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Intergroupe Francophone de Cancerologie Thoracique2
NCIC Clinical Trials Group2
Sun Yat-sen University2
Alpha Biopharma (Jiangsu) Co., Ltd.1
Betta Pharmaceuticals Co., Ltd.1
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1
Chinese Academy of Medical Sciences1
Dong-A University Hospital1
Hadassah Medical Organization1
Hamamatsu University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung22
Lung Neoplasms6
Brain Neoplasms2
Neoplasms2
Adenocarcinoma of Lung1
Adenocarcinoma, Bronchiolo-Alveolar1
Carcinoma, Squamous Cell1
Colorectal Neoplasms1
Esophageal Neoplasms1
Pancreatic Neoplasms1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.